Your browser doesn't support javascript.
loading
Production of highly branched α-limit dextrins with enhanced slow digestibility by various glycogen-branching enzymes.
Shim, Ye-Eun; Song, Young-Bo; Yoo, Sang-Ho; Lee, Byung-Hoo.
Affiliation
  • Shim YE; Department of Food Science and Biotechnology, Gachon University, Seongnam 13120, Republic of Korea; Core-Facility for Bionano Materials, Gachon University, Seongnam 13120, Republic of Korea.
  • Song YB; Department of Food Science and Biotechnology, Gachon University, Seongnam 13120, Republic of Korea.
  • Yoo SH; Department of Food Science and Biotechnology and Carbohydrate Bioproduct Research Center, Sejong University, Seoul 05006, Republic of Korea.
  • Lee BH; Department of Food Science and Biotechnology, Gachon University, Seongnam 13120, Republic of Korea. Electronic address: blee@gachon.ac.kr.
Carbohydr Polym ; 310: 120730, 2023 Jun 15.
Article in En | MEDLINE | ID: mdl-36925263
ABSTRACT
α-Limit dextrins (α-LDx) are slowly digestible carbohydrates that attenuate postprandial glycemic response and trigger the secretion of satiety-related hormones. In this study, more highly branched α-LDx were enzymatically synthesized to enhance the slowly digestible property by various origins of glycogen branching enzyme (GBE), which catalyzes the transglycosylation to form α-1,6 branching points after cleaving α-1,4 linkages. Results showed that the proportion of branched α-LDx in starch molecules increased around 2.2-8.1 % compared to α-LDx from starch without GBE treatment as the ratio of α-1,6 linkages increased after different types of GBE treatments. Furthermore, the enzymatic increment of branching points enhanced the slowly digestible properties of α-LDx at the mammalian α-glucosidase level by 17.3-28.5 %, although the rates of glucose generation were different depending on the source of GBE treatment. Thus, the highly branched α-LDx with a higher amount of α-1,6 linkages and a higher molecular weight can be applied as a functional ingredient to deliver glucose throughout the entire small intestine without a glycemic spike which has the potential to control metabolic diseases such as obesity and type 2 diabetes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / 1,4-alpha-Glucan Branching Enzyme Limits: Animals / Humans Language: En Journal: Carbohydr Polym Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / 1,4-alpha-Glucan Branching Enzyme Limits: Animals / Humans Language: En Journal: Carbohydr Polym Year: 2023 Document type: Article